drugset / Trial / NCT00537615

An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers

NCT00537615

Phase 1 Completed 6 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to investigate the absorption, metabolism and excretion of \[14C\] PD 0332334 to characterize plasma, fecal and urinary radioactivity and identify any metabolites of \[14C\] PD 0332334.

Timeline

Start
2007-09
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject IMAGABALIN Other / unclassified